This is the current revision of this page, as edited by Whywhenwhohow (talk | contribs) at 06:44, 24 November 2024 (script-assisted date audit and style fixes per MOS:NUM). The present address (URL) is a permanent link to this version.
Revision as of 06:44, 24 November 2024 by Whywhenwhohow (talk | contribs) (script-assisted date audit and style fixes per MOS:NUM)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Ionic compound (NaF)
Names | |
---|---|
Pronunciation | /ˌsoʊdiəm ˈflʊəraɪd/ |
IUPAC name Sodium fluoride | |
Other names Florocid | |
Identifiers | |
CAS Number | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.028.789 |
EC Number |
|
KEGG | |
PubChem CID | |
RTECS number |
|
UNII | |
UN number | 1690 |
CompTox Dashboard (EPA) | |
InChI
| |
Properties | |
Chemical formula | NaF |
Molar mass | 41.988173 g/mol |
Appearance | White to greenish solid |
Odor | odorless |
Density | 2.558 g/cm |
Melting point | 993 °C (1,819 °F; 1,266 K) |
Boiling point | 1,704 °C (3,099 °F; 1,977 K) |
Solubility in water | 36.4 g/L (0 °C); 40.4 g/L (20 °C); 50.5 g/L (100 °C) |
Solubility | slightly soluble in HF, ammonia negligible in alcohol, acetone, SO2, dimethylformamide |
Vapor pressure | 1 mmHg @ 1077 °C |
Acidity (pKa) | 3,20 (weak base, see HF) |
Magnetic susceptibility (χ) | −16.4·10 cm/mol |
Refractive index (nD) | 1.3252 |
Structure | |
Crystal structure | Cubic |
Lattice constant | a = 462 pm |
Molecular shape | Octahedral |
Thermochemistry | |
Heat capacity (C) | 46.82 J/(mol K) |
Std molar entropy (S298) |
51.3 J/(mol K) |
Std enthalpy of formation (ΔfH298) |
-573.6 kJ/mol |
Gibbs free energy (ΔfG) | -543.3 kJ/mol |
Pharmacology | |
ATC code | A01AA01 (WHO) A12CD01 (WHO), V09IX06 (WHO) (F) |
Hazards | |
GHS labelling: | |
Pictograms | |
Signal word | Danger |
Hazard statements | H301, H315, H319, H335 |
NFPA 704 (fire diamond) | 3 0 0 |
Flash point | Non-flammable |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose) | 52–130 mg/kg (oral in rats, mice, rabbits) |
NIOSH (US health exposure limits): | |
PEL (Permissible) | TWA 2.5 mg/m |
REL (Recommended) | TWA 2.5 mg/m |
IDLH (Immediate danger) | 250 mg/m (as F) |
Safety data sheet (SDS) | |
Related compounds | |
Other anions | Sodium chloride Sodium bromide Sodium iodide Sodium astatide |
Other cations | Lithium fluoride Potassium fluoride Rubidium fluoride Caesium fluoride Francium fluoride |
Related compounds | TASF reagent |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
Sodium fluoride (NaF) is an inorganic compound with the formula NaF. It is a colorless or white solid that is readily soluble in water. It is used in trace amounts in the fluoridation of drinking water to prevent tooth decay, and in toothpastes and topical pharmaceuticals for the same purpose. In 2022, it was the 221st most commonly prescribed medication in the United States, with more than 1 million prescriptions. It is also used in metallurgy and in medical imaging.
Uses
Dental caries
See also: Fluoride therapy and Water fluoridationFluoride salts are often added to municipal drinking water (as well as to certain food products in some countries) for the purpose of maintaining dental health. The fluoride enhances the strength of teeth by the formation of fluorapatite, a naturally occurring component of tooth enamel. Although sodium fluoride is used to fluoridate water and is the standard by which other water-fluoridation compounds are gauged, hexafluorosilicic acid (H2SiF6) and its salt sodium hexafluorosilicate (Na2SiF6) are more commonly used additives in the United States.
Osteoporosis
Fluoride supplementation has been extensively studied for the treatment of postmenopausal osteoporosis. This supplementation does not appear to be effective; even though sodium fluoride increases bone density, it does not decrease the risk of fractures.
Medical imaging
In medical imaging, fluorine-18-labelled sodium fluoride (USP, sodium fluoride NaF) is one of the oldest tracers used in positron emission tomography (PET), having been in use since the 1960s. Relative to conventional bone scintigraphy carried out with gamma cameras or SPECT systems, PET offers more sensitivity and spatial resolution. Fluorine-18 has a half-life of 110 min, which requires it to be used promptly once produced; this logistical limitation hampered its adoption in the face of the more convenient technetium-99m-labelled radiopharmaceuticals. However, fluorine-18 is generally considered to be a superior radiopharmaceutical for skeletal imaging. In particular it has a high and rapid bone uptake accompanied by very rapid blood clearance, which results in a high bone-to-background ratio in a short time. Additionally the annihilation photons produced by decay of F have a high energy of 511 keV compared to the 140 keV photons of Tc.
Chemistry
Sodium fluoride has a variety of specialty chemical applications in synthesis and extractive metallurgy. It reacts with electrophilic chlorides including acyl chlorides, sulfur chlorides, and phosphorus chloride. Like other fluorides, sodium fluoride finds use in desilylation in organic synthesis. Sodium fluoride can be used to produce fluorocarbons via the Finkelstein reaction; this process has the advantage of being simple to perform on a small scale but is rarely used on an industrial scale due to the existence of more effective techniques (e.g. Electrofluorination, Fowler process).
Biology
Sodium fluoride is sometimes added at relatively high concentrations (~20 mM) to protein lysis buffers in order to inhibit endogenous phosphatases and thereby protect phosphorylated protein sites. Sodium pyrophosphate and Sodium orthovanadate are also used for this purpose.
Insecticide
Inorganic fluorides such as fluorosilicates and sodium fluoride complex magnesium ions as magnesium fluorophosphate. They inhibit enzymes such as enolase that require Mg as a prosthetic group. Thus, fluoride poisoning prevents phosphate transfer in oxidative metabolism. Sodium fluoride, patented as an insecticide in 1896, was commonly used through the 1970s on ants and other domestic pests, and as a stomach poison for plant-feeding insects.
Its use, along with that of sodium fluorosilicate, declined over the 20th century as the products were banned or restricted due to the possibility of poisoning, intentional or accidental. In 1942, for instance, 47 inmates at the Oregon State Hospital died after consuming scrambled eggs which had been inadvertently prepared with sodium fluoride; while assisting the cooks, another inmate had confused a container of insecticide—used by the hospital to control cockroaches—with powdered milk, which was stored nearby.
Other uses
Sodium fluoride is used as a cleaning agent (e.g., as a "laundry sour").
Sodium fluoride can be used in a nuclear molten salt reactor.
Safety
See also: Fluoride poisoningThe lethal dose for a 70 kg (154 lb) human is estimated at 5–10 g.
Fluorides, particularly aqueous solutions of sodium fluoride, are rapidly and quite extensively absorbed by the human body.
Fluorides interfere with electron transport and calcium metabolism. Calcium is essential for maintaining cardiac membrane potentials and in regulating coagulation. High ingestion of fluoride salts or hydrofluoric acid may result in fatal arrhythmias due to profound hypocalcemia. Chronic over-absorption can cause hardening of bones, calcification of ligaments, and buildup on teeth. Fluoride can cause irritation or corrosion to eyes, skin, and nasal membranes.
Sodium fluoride is classed as toxic by both inhalation (of dusts or aerosols) and ingestion. In high enough doses, it has been shown to affect the heart and circulatory system. For occupational exposures, the Occupational Safety and Health Administration and the National Institute for Occupational Safety and Health have established occupational exposure limits at 2.5 mg/m over an eight-hour time-weighted average.
In the higher doses used to treat osteoporosis, plain sodium fluoride can cause pain in the legs and incomplete stress fractures when the doses are too high; it also irritates the stomach, sometimes so severely as to cause peptic ulcer disease. Slow-release and enteric-coated versions of sodium fluoride do not have significant gastric side effects, and have milder and less frequent complications in the bones. In the lower doses used for water fluoridation, the only clear adverse effect is dental fluorosis, which can alter the appearance of children's teeth during tooth development. A chronic fluoride ingestion of 1 ppm of fluoride in drinking water can cause mottling of the teeth (fluorosis) and an exposure of 1.7 ppm will produce mottling in 30%–50% of patients. Studies have shown that dental fluorosis negatively impacts the self-esteem and self-image of adolescents.
Chemical structure
Sodium fluoride is an inorganic ionic compound, dissolving in water to give separated Na and F ions. Like sodium chloride, it crystallizes in a cubic motif where both Na and F occupy octahedral coordination sites; its lattice spacing, approximately 462 pm, is smaller than that of sodium chloride (564 pm).
Occurrence
The mineral form of NaF, villiaumite, is moderately rare. It is known from plutonic nepheline syenite rocks.
Production
NaF is prepared by neutralizing hydrofluoric acid or hexafluorosilicic acid (H2SiF6), both byproducts of the reaction of fluorapatite (Ca5(PO4)3F) from phosphate rock during the production of superphosphate fertilizer. Neutralizing agents include sodium hydroxide and sodium carbonate. Alcohols are sometimes used to precipitate the NaF:
- HF + NaOH → NaF + H2O
From solutions containing HF, sodium fluoride precipitates as the bifluoride salt sodium bifluoride (NaHF2). Heating the latter releases HF and gives NaF.
- HF + NaF ⇌ NaHF2
In a 1986 report, the annual worldwide consumption of NaF was estimated to be several million tonnes.
See also
References
- Wells JC (2008), Longman Pronunciation Dictionary (3rd ed.), Longman, pp. 313 and 755, ISBN 978-1-4058-8118-0. According to this source, an alternative pronunciation of the second word is /ˈflɔːraɪd/ and, in the UK, also /ˈfluːəraɪd/.
- Haynes, William M., ed. (2011). CRC Handbook of Chemistry and Physics (92nd ed.). CRC Press. p. 5.194. ISBN 978-1-4398-5511-9.
- Lewis, R.J. Sax's Dangerous Properties of Industrial Materials. 10th ed. Volumes 1–3 New York, NY: John Wiley & Sons Inc., 1999., p. 3248
- ^ Sigma-Aldrich Co., Sodium Fluoride.
- ^ NIOSH Pocket Guide to Chemical Hazards. "#0563". National Institute for Occupational Safety and Health (NIOSH).
- Martel, B., Cassidy, K. (2004), Chemical Risk Analysis: A Practical Handbook, Butterworth–Heinemann, p. 363, ISBN 978-1-903996-65-2
- "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
- "Sodium Fluoride Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
- Bourne GH (1986). Dietary research and guidance in health and disease. Basel: Karger. p. 153. ISBN 978-3-8055-4341-5.
- Klein C (1999). Hurlbut CS (ed.). Manual of Mineralogy (after James D. Dana) (21st ed., rev. ed.). New York: J. Wiley. ISBN 978-0-471-31266-6.
- Selwitz RH, Ismail AI, Pitts NB (January 2007). "Dental caries". The Lancet. 369 (9555): 51–59. doi:10.1016/S0140-6736(07)60031-2. PMID 17208642. S2CID 204616785.
- Division of Oral Health, National Center for Prevention Services, CDC (1993), Fluoridation census 1992 (PDF), retrieved 29 December 2008.
{{citation}}
: CS1 maint: multiple names: authors list (link) - Haguenauer D, Welch V, Shea B, Tugwell P, Wells G (2000). "Fluoride for treating postmenopausal osteoporosis". The Cochrane Database of Systematic Reviews. 2010 (4): CD002825. doi:10.1002/14651858.CD002825. PMC 8453489. PMID 11034769.
- Vestergaard P, Jorgensen NR, Schwarz P, Mosekilde L (March 2008). "Effects of treatment with fluoride on bone mineral density and fracture risk—a meta-analysis". Osteoporosis International. 19 (3): 257–68. doi:10.1007/s00198-007-0437-6. PMID 17701094. S2CID 25890845.
- Blau M, Ganatra R, Bender MA (January 1972). "18F-fluoride for bone imaging". Seminars in Nuclear Medicine. 2 (1): 31–37. doi:10.1016/S0001-2998(72)80005-9. PMID 5059349.
- Ordonez AA, DeMarco VP, Klunk MH, Pokkali S, Jain S (October 2015). "Imaging Chronic Tuberculous Lesions Using Sodium [18F]Fluoride Positron Emission Tomography in Mice". Molecular Imaging and Biology. 17 (5): 609–614. doi:10.1007/s11307-015-0836-6. PMC 4561601. PMID 25750032.
- Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST (12 December 2007). "Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer". Journal of Nuclear Medicine. 49 (1): 68–78. doi:10.2967/jnumed.106.037200. PMID 18077529.
- Halpern D (2001), "Sodium Fluoride", Encyclopedia of Reagents for Organic Synthesis, John Wiley & Sons, doi:10.1002/047084289X.rs071, ISBN 978-0-471-93623-7
- Somerville LL, Wang K (1988). "Sarcomere matrix of striated muscle: In vivo phosphorylation of titin and nebulin in mouse diaphragm muscle". Archives of Biochemistry and Biophysics. 262 (1). Elsevier BV: 118–129. doi:10.1016/0003-9861(88)90174-9. ISSN 0003-9861. PMID 3355162.
- "Overview of Protease and Phosphatase Inhibition for Protein Preparation - US". Thermo Fisher Scientific. 10 May 2017. Retrieved 3 February 2023.
- Metcalf, Robert L. (2007), "Insect Control", Ullmann's Encyclopedia of Industrial Chemistry (7th ed.), Wiley, p. 9
- ^ Weinstein L, Davison A (2004). Fluorides in the Environment: Effects on Plants and Animals. CABI Publishing. p. 76. ISBN 9780851998725.
- House JE, House KA (10 September 2015). Descriptive Inorganic Chemistry. Academic Press. p. 397. ISBN 978-0-12-802979-4.
- "Unsuspecting Poisoner of 47 At a Hospital in 1942 Is Dead". The New York Times. 4 October 1983. Archived from the original on 20 August 2016. Retrieved 4 August 2016.
- ^ Aigueperse J, Mollard P, Devilliers D, Chemla M, Faron R, Romano R, et al. (2000). "Fluorine Compounds, Inorganic". Ullmann's Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH. doi:10.1002/14356007.a11_307. ISBN 3-527-30673-0.
- ^ Kapp, Robert (2005), "Fluorine", Encyclopedia of Toxicology, vol. 2 (2nd ed.), Elsevier, pp. 343–346
- Greene Shepherd (2005), "Fluoride", Encyclopedia of Toxicology, vol. 2 (2nd ed.), Elsevier, pp. 342–343
- NaF MSDS. hazard.com
- CDC – NIOSH Pocket Guide to Chemical Hazards
- Murray TM, Ste-Marie LG (1996). "Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 7. Fluoride therapy for osteoporosis". CMAJ. 155 (7): 949–54. PMC 1335460. PMID 8837545.
- Molina-Frechero N, Nevarez-Rascón M, Nevarez-Rascón A, González-González R, Irigoyen-Camacho ME, Sánchez-Pérez L, et al. (12 January 2017). "Impact of Dental Fluorosis, Socioeconomic Status and Self-Perception in Adolescents Exposed to a High Level of Fluoride in Water". International Journal of Environmental Research and Public Health. 14 (1): 73. doi:10.3390/ijerph14010073. PMC 5295324. PMID 28085102.
- Nilchian F, Asgary I, Mastan F (July 2018). "The Effect of Dental Fluorosis on the Quality of Life of Female High School and Precollege Students of High Fluoride-Concentrated Area". Journal of International Society of Preventive & Community Dentistry. 8 (4): 314–319. doi:10.4103/jispcd.JISPCD_94_18. PMC 6071349. PMID 30123763.
- Wells A (1984), Structural Inorganic Chemistry, Oxford: Clarendon Press, ISBN 978-0-19-855370-0
- "Chemical and physical information", Toxicological profile for fluorides, hydrogen fluoride, and fluorine (PDF), Agency for Toxic Substances and Disease Registry (ATDSR), September 2003, p. 187, retrieved 1 November 2008
- Mineral Handbook (PDF), Mineral Data Publishing, 2005.
Sodium compounds | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inorganic |
| ||||||||||||||
Organic |